Holen Sie sich die Stockscreener-App
30.09
2.62%
-0.81
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates - Yahoo! Finance Canada
Earnings call transcript: TG Therapeutics Q4 2025 earnings miss EPS expectations - Investing.com
TG Therapeutics: Fourth Quarter Financial Highlights - Bitget
TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook - ChartMill
TG Therapeutics (TGTX) Reports Q4 Earnings Miss - GuruFocus
TGTX Projects Strong Financial Performance Through 2026 - GuruFocus
TGTX Financial Health and Future Funding Outlook - GuruFocus
TG THERAPEUTICS ($TGTX) Releases Q4 2025 Earnings - Quiver Quantitative
TG Therapeutics Q4 revenue rises on BRIUMVI sales, but profit dips - TradingView
TG Therapeutics: Q4 Earnings Snapshot - marketscreener.com
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
TG Therapeutics Q4 Earnings Assessment - Benzinga
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance - GlobeNewswire
TG Therapeutics, Inc. $TGTX Stock Holdings Increased by Citigroup Inc. - MarketBeat
A Look at TG Therapeutics's Upcoming Earnings Report - Benzinga
TG Therapeutics faces earnings test as Briumvi growth accelerates - Investing.com India
TG Therapeutics (TGTX) Set to Announce Q4 Earnings with Positive Revisions - GuruFocus
Vanguard Group Inc. Lowers Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
FOMO Trade: Is TG Therapeutics Inc a top pick in the sectorWeekly Stock Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Goldman Sachs raises TG Therapeutics, Inc. (TGTX) target to $39 on 2026 guidance - MSN
Aug Rallies: Is TG Therapeutics Inc undervalued by DCF analysisWeekly Investment Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
TG Therapeutics, Inc. (TGTX) Stock Analysis: A 50% Upside Potential In Biotech - DirectorsTalk Interviews
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Finviz
TG Therapeutics to Host Conference Call Discussing Q4 and Full Year 2025 Financial Results and 2026 Outlook - Quiver Quantitative
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update - marketscreener.com
TG Therapeutics (TGTX) to Release Earnings on Monday - MarketBeat
Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares - AOL.com
What are TG Therapeutics Inc.’s recent SEC filings showing2025 EndofYear Setup & Safe Capital Preservation Plans - mfd.ru
What is TG Therapeutics Inc.’s valuation compared to sectorDay Trade & Smart Swing Trading Alerts - mfd.ru
Persistent Asset Partners Ltd Sells 71,539 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Will TG Therapeutics Inc. benefit from AI trendsForecast Cut & AI Enhanced Trading Signals - mfd.ru
TG Therapeutics, Inc. Announces the Publication of Long Term/Five-Year Data from the Ongoing Open-Label Extension of the Phase 3 Ultimate I and Ii Studies - marketscreener.com
5-year MS study: BRIUMVI patients average one relapse every 50 years - Stock Titan
Liquidity Mapping Around (TGTX) Price Events - Stock Traders Daily
Portfolio Shifts: Should you avoid TG Therapeutics Inc stock right now2025 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
TG Therapeutics, Inc. (TGTX) Stock Analysis: A 55.89% Potential Upside in the Biotech Space - DirectorsTalk Interviews
What are TG Therapeutics Inc.’s growth leversJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - mfd.ru
TG Therapeutics, Inc. $TGTX Shares Bought by Public Sector Pension Investment Board - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Downgraded by Wall Street Zen to "Hold" - MarketBeat
TGTX Stock Price, Forecast & Analysis | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
Goldman Sachs Raises TG Therapeutics, Inc. (TGTX) Target to $39 on 2026 Guidance - Insider Monkey
Should you avoid TG Therapeutics Inc. stock right now2025 Sector Review & Free Risk Controlled Daily Trade Plans - mfd.ru
Why TG Therapeutics Inc. (NKB2) stock gets analyst attentionTrade Entry Report & Community Supported Trade Ideas - mfd.ru
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
TG Therapeutics (TGTX) sees price target drop from JPMorgan - MSN
Should New BRIUMVI Data and MS Campaign Shift TG Therapeutics' (TGTX) Narrative on Commercial Execution? - Yahoo Finance
TG Therapeutics lights up Super Bowl with Christina Applegate MS campaign — retail sees 'huge win' - MSN
TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' - Stocktwits
MSFT Vs AMZN Vs GOOGL: Which Cloud Stock Is A Better Bet? - Stocktwits
TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - GlobeNewswire
Christina Applegate fronts new MS honesty campaign with TG Therapeutics - Stock Titan
TG Therapeutics Partners with Christina Applegate to Raise MS Awareness - intellectia.ai
1.18%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):